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Summary: Hormonal regulation of glycogen synthase and phosphorylase activities were studied in human
polymorphonuclear leukocytes. Polymorphonuclear leukocytes from normal subjects were incubated with
glucose, insulin, ΑΖ,-isoproterenol and L-thyroxine, either independently or in different combinations, and
changes of the enzyme activity ratios of glycogen synthase (active form (I) / total activity (T)) and glycogen
phosphorylase (active form (a) / total activity (T)) were assessed.
Neither glucose nor insulin changed the glycogen synthase activity ratio. However, the proportion of the
active form (I) of glycogen synthase was increased by the simultaneous addition of glucose and insulin to the
incubation mixture, but D,L-isoproterenol or L-thyroxine diminished this effect and caused a decrease in the
proportion of the active form of glycogen synthase.
Insulin had no effect on the glycogen phosphorylase activity ratio. Glucose decreased the proportion of
phosphorylase in the a form. The simultaneous addition of glucose and insulin caused no further changes,
whereas in the presence of AL-isoproterenol or L-thyroxine, this glucose effect was abolished and the
proportion of phosphorylase a increased.
These results show that both thyroid hormone and a -agonist alter glycogen metabolism to reduce glycogen
storage in polymorphonuclear leukocytes.
Introduction · * · * < · u u i j u ^ ^exists in two forms, phosphorylase a and b, and the
Glycogen synthase (UDP-glucose: glycogen 4oc-Z>-glu- former is more active than the latter. The fractional
cosyl transferase, EC 2.4.1.11) is a rate limiting factor activity of glycogen phosphorylase, which is subse-
in mammalian glycpgenesis and, in consequence, a quently referred to as "glycogen phosphorylase activ-
pivotal point of hormonal control: It exists in an ity ratio", is calculated from the ratio of phosphoryl-
active form (I) and a less active D form which is ase a activity to total phosphorylase activity (a/T) (2).
dependent on glucose-6-^phosphate. The total amount _^ ,,. . ^
 A , , j «. * ι/Lu .. /τ,ν \^ Λ · u Decreased liver glycogen content and decreased totalof the synthase (T) can be measured in the presence , . ο ^ ο
* + ' * . *
 A - r ι *· i_ L glycogen synthase activity were observed in hyperthy-of saturating concentrations of glucoses-phosphate. ., / * j -^ r Ii. · r r j ,1\τ,, p
 A. .4 4. /T/r~ £ .j ~ , roid rats treated with L-thyroxme for forty days (3).The enzyme activity ratio (I/T) thus provides a useful J j r n /
• Λ r r n - t . · ι. * · · In addition, several hormones such as adrenalin, D.L-index for following changes in the state of activation · ' , · , ·
 Λ , , ,
-Λ /<ιλ
ρ
 isoproterenol, insulin and glucagon are also known
of the enzyme (1).
 A «· 4 ι ^ Λ u u iJ
 ^ ' to affect glycogen synthase and phosphorylase activ-
Breakdown of glycogen is limited by the activity of ities (4—11). However, no study has been reported
glycogen phosphorylase (oc-l,4-glucan : orthophos- on the effect of thyroid hormone on these enzymes
phate glucosyltransferase, EC 2.4.1.1). The enzyme using human tissue cells.
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In the present study, to investigate the hormonal
regulation of these enzyme activities, we carried out
the in vitro incubation of human polymorphonuclear
leukocytes with glucose, insulin, Z),L-isoproterenol
and L-thyroxine, since polymorphonuclear leukocytes
are easily available from human tissues and contain
a sufficient amount of glycogen (12).
Materials and Methods
Materials
UDP-[14C]glucose (specific activity 11.9 GBq/mmol) was pur-
chased from New England Nuclear and oc-£>-[U-I4C]glucose-l-
phosphate (specific activity 11.6 GBq/mmol) was from Amer-
sham International pic. UDP-glucose, glucose-1-phosphate,
glucose-6-phosphate, porcine insulin and AL-isoproterenol
were from Sigma. L-Thyroxine was a generous gift from Takeda
Chemical Industry. Ficoll-Hypaque was from Pharmacia. All
other reagents were of the highest purity commercially avail-
able.
Separation of polymorphonuclear leukocytes
Twenty ml of heparinized venous blood was collected from
non-diabetic subjects and polymorphonuclear leukocytes were
isolated by dextran sedimentation of the erythrocytes and dif-
ferential centrifugation of the polymorphonuclear leukocytes
using Ficoll-Hypaque. Contaminating erythrocytes were hae-
molysed by 8.7 g/l NH4C1, pH 7.4. Polymorphonuclear leuko-
cytes were suspended at a concentration of 20 χ 109/1 in a
buffer consisting of 50 mmol/1 Tris-HCl and 5 mmol/1 EDTA,
pH 7.8 (12, 13).
Glycogen synthase assay
In the preliminary study, to assess the effect of L-thyroxine on
glycogen synthase activity, we incubated polymorphonuclear
leukocytes with various concentrations of L-thyroxine for the
indicated times as shown in figure 1. Apparently, the maximal
effect of L-thyroxine was obtained at the concentration of 3.2
μιηοΐ/ΐ (A) and at the time of 2 min (B).
The effect of glucose, insulin and Z>,L-isoproterenol on the
glycogen synthase activity was examined as described by Juki
et al. (7) with slight modifications. Briefly, suspensions of po-
lymorphonuclear leukocytes were preincubated in the buffer
for 5 min and then incubated with 30 mmol/1 glucose and/or
1.62 nmol/1 insulin for 4 min, and/or 1 μπιοΙ/1 Z),L-isoproterenol
for l min and/or 3.2 μιηοΐ/ΐ L-thyroxine for 2 min individually
and together. All incubations were done at 37 °C. The suspen-
sions were then ultrasonically disrupted with 100 mmol/1 NaF.
This crude homogenate was then centrifuged at 10000 min~J
for 5 min at 4 °C using a microfuge and the supernatant was
assayed with a mixture containing 6.7 mmol/1 UDP-[14C]glucose
and 0.6 mg glycogen, with or without 6.7 mmol/1 glucose-6-
phosphate, for 10 min at 37 °C according to the method de-
scribed by Thomas et al. (1).
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Fig. l. Effect of L-thyroxine on the glycogen synthase activity
in human polymorphonuclear leukocytes.
a) Changing fractions of glycogen synthase activity ratio
after incubation with L-thyroxine for 2 min. Changes
of enzyme activity ratio were estimated at various con^
centrations of L-thyroxine. Data are shown as means
of four determinations in two separate experiments.
b) Changing fractions of enzyme activity ratio after
incubation with 3.2 μηιοΐ/ΐ L-thyroxine. Changes of
enzyme activity ratio were estimated at indicated times.
Data represent means of four determinations in two
separate experiments.
according to Gilboe et al. (2). Briefly, the enzyme activity was
determined in the presence of 20 mmol/1 [14C]glucose-l-phos-
phate, 10 g/1 glycogen, 12.5 mmol/1 NaF with 0.5 mmol/1
caffeine (phosphorylase a activity) or with 3 mmol/1 AMP (total
phosphorylase activity).
Statistical analysis
Statistical differences between the groups were established with
Studenfs t test. Results are presented as mean ± SD.
Glycogen phosphorylase assay
Polymorphonuclear leukocytes were incubated with several re^
agents under the same conditions described above. Incubations
were stopped by the addition of MES buffer (10 mmol/1 MES
(morpholinoethanesulphonic acid), 50 mmol/I NaF, 25 mmol/1
-glycerophosphate, 10 mmol/1 EDTA containing 0.1 mg digi-
tonin, pH 6.1). Glycogen phosphorylase activity was measured
Results
Changes of glycogen synthase and phosphorylase ac-
tivity ratios are summarized in table 1 and 2, respec-
tively. The effect of glucose and insulin on the gly-
cogen synthase activity ratio is graphed in figure 2.
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Tab. 1. Changes of glycogen synthase activity (fraction of I) after incubation with various reagents.
Effectors Before After Significance
Glucose
Insulin
Glucose + Insulin
/),L-Isoproterenol
L-Thyroxine
£,L-Isoproterenol H- L-Thyroxine
Glucose -f Insulin H- Z),L-Isoproterenol
Glucose + Insulin 4· L-Thyroxine
0.322 ± 0.108
0.290 ± 0.149
0.362 ± 0.100
0.415 ± 0.101
0.423 ± 0.059
0.393 + 0.103
0.390 ± 0.098
0.434 ± 0.046
0.335 ± 0.104 (6)
0.282 ± 0.184 (6)
0.531 ± 0.129 (5)
0.246 ± 0.149 (5)
0.252 ±0.091 (5)
0.163 ±0.117 (4)
0.210 ± 0.116 (7)
0.237 4- 0.104 (5)
NS
NS
p < 0.02
p < 0.05
p < 0.005
p < 0.01
p < 0.001
p < 0.005
Results are expressed as means ± SD, with the number of experiments in parentheses. Statistically significant with respect to
preincubation values.
Tab. 2. Changes of glycogen phosphorylase activity (fraction of a) after incubation with various reagents.
Effectors Before After Significance
Glucose
Insulin
Z),L-Isoproterenol
L-Thyroxine
Glucose + AL-Isoproterenol
Glucose -f L-Thyroxine
0.472 ± 0.044
0.452 + 0.045
0.442 + 0.051
0.434 ± 0.065
0.378 ± 0.024
0.388 -f 0.014
0.343 ± 0.026 (4)
0.466 ± 0.051 (6)
0.606 + 0.088 (4)
0.553 ± 0.083 (5)
0.504 ± 0.019 (4)
0.493 ± 0.019 (3)
ρ < 0.005
NS
ρ < 0.02
ρ < 0.02
ρ < 0.005
ρ < 0.02
Results are expressed as means ± SD, with the number of experiments in parentheses. Statistically significant with respect to
preincubation values.
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after incubation with AL-isoproterenol or L-thyrox-
ine. Both reagents caused the enzyme activity ratio to
decrease. Treatment with Z>,£-isoproterenol decreased
the values for synthase I from 0.415 ±0.101 to 0.246
± 0.149 (p < 0.05). With L-thyroxine treatment, the
values for synthase I decreased from 0.423 + 0.059
to 0.252 ± 0.091 (p < 0.005). When polymorphonu-
clear leukocytes were incubated with L>,L-isoproter-
enol and i-thyroxine at the same time, a slightly
Fig. 2. Effect of glucose and insulin on the glycogen synthase
activity in human polymorphonuclear leukocytes. Cells
were incubated with 30 mmol/1 glucose and/or 1.62
nmol/1 insulin for 4 min at 37 °C. The fractions of syn-
thase I were measured before and after the incubation.
The proportions of glycogen synthase I were 0.322
± 0.108 and 0.335 + 0.104, before and after treat-
ment with glucose, respectively. By treatment with
insulin, the values of synthase Ϊ were changed from
0.290 ± 0.149 to 0.282 ± 0.184. From these data,
neither glucose nor insulin had an apparent effect on
the enzyme activity ratio. When polymorphonuclear
leukocytes were incubated with both glucose and in-
sulin, the values for synthase I increased from 0.362
± 0.100 to 0.531 ± 0.129 (p < 0.02). Figure 3 shows
the changes in the proportion of glyeogen synthase I
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Fig. 3. Effect of />,L-isoprotefenol and L-thyroxine on the glu-
cogen synthase activity in human polymorphonuclear
leukocytes. Cells were incubated with 1 μηιοΐ/ΐ D,L-
isoproterenol for l min and/or 3.2 μιηοΐ/ΐ L-thyroxine
for 2 min at 37 °C. The fractions of synthase I were
measured before and after the incubation.
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Fig. 4. Effect of £,L-isoproterenol and L-thyroxine on the frac-
tions of synthase I increased by glucose plus insulin.
Cells were incubated with 30 mmol/1 glucose plus 1.62
nmol/1 insulin and 1 μηιοΐ/l Z>,L-isoproterenol or 3.2
μιηοΐ/ΐ L-thyroxine for 4 min at 37 °C. The fractions of
synthase I were measured before and after the incuba-
tion.
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Fig. 6. Effect of L>,L-isoproterenol and L-thyroxine on the gly-
cogen phosphorylase activity in human polymorpho-
nuciear leukocytes. Incubations were done under the
same conditions as described in fig. 3. The fractions of
phosphorylase a were measured before and after the
incubation.
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Fig. 5. Effect of glucose and insulin on the glycogen phospho-
rylase activity in human polymorphonuclear leukocytes.
Incubations were done under the same conditions as
described in fig. 2. The fractions of phosphorylase a
were measured before and after the incubation.
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Fig. 7. Effect of glucose plus Z),L-isoproterenol and glucose
plus L-thyroxine on the glycogen phosphorylase activity
in human polymorphonuclear leukocytes. Incubations
were done for 4 min at 37 °C. The fractions of phos-
phorylase a were measured before and after the incu-
bation.
augmented decrease in the values for synthase I were
observed: 0.393 ±0.103 and 0.163 ±0.117 before
and after treatment, respectively (p < 0.01). Then we
examined the effects of D,L-isoproterenol and L-thy-
roxine on the upward changes of the enzyme activity
ratio induced by glucose plus insulin. Both L>,L-iso-
proterenol and L-thyroxine decreased the enzyme ac-
tivity ratio, which would normally be increased by
simultaneous incubation with glucose and insulin (fig.
4). D,L-isoproterenol decreased the values for syn-
thase I from 0.390 ± 0.098 to 0.210 ± 0.116
(p < 0.001). L-Thyroxine treatment caused the values
for synthase I to decrease from 0.434 ± 0.046 to 0.237
± 0.104 (p < 0.005).
Figure 5 shows the effect of glucose and insulin on
the glycogen phosphorylase activity ratio. Insulin had
no effect on the glycogen phosphorylase activity ratio,
but glucose apparently decreased the enzyme activity
ratio. The values for phosphorylase a decreased from
0.472 ± 0.044 to 0.343 ± 0.026 (p < 0.005). Glucose
plus insulin showed no further changes of the enzyme
activity ratio (data not shown). Z),L-isoproterenol and
L-thyroxine increased the enzyme activity ratio (fig.
6). By treatment with D,L-isoproterenol, the values
for phosphorylase a increased from 0.442 ± 0.051 to
0.606 ± 0.088 (p < 0.02). With L-thyroxine treat-
ment, the values for phosphorylase a increased from
0.434 ± 0.065 to 0.553 + 0.083 (p < 0.02). When
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polymorphonuclear leukocytes were incubated with
glucose and Z),L-isoproterenol at the same time, the
decrease observed in the presence of glucose was abol-
ished, and the values for phosphorylase a increased
from 0.378 ± 0.024 to 0.504 ± 0.019 (Fig. 7,
p < 0.005). Incubation with glucose and L-thyroxine
simultaneously produced similar results, and the val-
ues for phosphorylase a increased from 0.388 ± 0.014
to 0.493 ± 0.019 (fig. 7, p < 0.02).
Discussion
Impaired glucose tolerance is frequently observed in
hyperthyroid patients (14—16). Glucose intolerance
has been ascribed to rapid gastric emptying and ab-
sorption of nutrients as well as increased splanchnic
gluconeogenic precursors and glycogenolytic turnover
rates (16 — 18), but the precise mechanisms leading to
glucose intolerance are not understood.
We studied in vitro effects of glucose, insulin, D,L-
isoproterenol and L-thyroxine, on glycogen synthase
and phosphorylase activities in polymorphonuclear
leukocytes. The levels of these compounds are thought
to change in hyperthyroidism. Glucose and insulin
are reported to increase the glycogen synthase activity
ratio in several animal tissues (4, 8 — 10, 19 — 21). On
the other hand, only a few experiments using human
tissues have been reported. Insulin was reported to
have no effect on the glycogen synthase activity ratio
in human polymorphonuclear leukocytes (6). Our
data show that neither insulin nor glucose had any
effect on the glycogen synthase activity ratio; however,
when polymorphonuclear leukocytes were incubated
with both of these compounds simultaneously, the
enzyme activity ratio increased. These results indicate
that in human polymorphonuclear leukocytes glucose
must be present in order for insulin to increase the
glycogen synthase activity ratio.
Insulin had no effect on glycogen phosphorylase ac-
tivity in rat tissue cells (10, 19); however, Hartmann
et al. reported that insulin decreased the basal and
the ghicagon-activated glycogen phosphorylase activ-
ity ratio in rat hepatocyte cultures (22). In human
skeletal muscle neither insulin nor glucose changed
glycogen phosphorylase activity (23). In human po-
lymorphonuclear leukocytes, glucose was reported to
decrease the glycogen phosphorylase activity ratio (7)
and this is in accordance with our results. But there
is no report concerning the effect of insulin on gly-
cogen phosphorylase activity in human polymor-
phonuclear leukocytes. In our experiments insulin had
no effect on glycogen phosphorylase activity. Insulin-
insensitive glycogen synthase and phosphorylase ac-
tivities in human polymorphonuclear leukocytes may
explain the findings of Esmann er al. that insulin had
no effect on the glycogen content of normal human
polymorphonuclear leukocytes (12).
Little is known about the effect of thyroid hormone
on the control of glycogen metabolism in human
polymorphonuclear leukocytes. To assess the effect of
hyperthyroxinaemia on the glycogen synthase and
glycogen phosphorylase activity ratios, we incubated
polymorphonuclear leukocytes in vitro with L-thy-
roxine. A decrease of the glycogen synthase and an
increase of the glycogen phosphorylase activity ratios
were observed. It is suggested that an excess of
L-thyroxine alters these enzyme activities in poly-
morphonuclear leukocytes.
Epinephrine and D,L-isoproterenol were reported to
decrease the glycogen synthase activity ratio (4, 9,11,
19, 20) and to increase the glycogen phosphorylase
activity ratio (19, 24) in animal tissues. Juki et al. (7)
reported that Z),L-isoproterenol did not change the
glycogen synthase activity ratio but increased the gly-
cogen phosphorylase activity ratio in human poly-
morphonuclear leukocytes. In our experiments D,L-
isoproterenol decreased the glycogen synthase activity
ratio and increased the glycogen phosphorylase activ-
ity ratio. These other authors reported a basal gly-
cogen synthase activity ratio which was very much
lower than our values, and they probably could not
detect the apparent changes in glycogen synthase ac-
tivity without evaluating the phosphorylation of this
enzyme.
Next we examined the effect of D,L-isoproterenol and
L-thyroxine on the glycogen synthase activity ratio
stimulated by glucose plus insulin. Both D,L-isopro-
terenol and L-thyroxine diminished the glycogen syn-
thase activity ratio which should have been enhanced
by glucose plus insulin. Lawrence et al. (9) reported
that in rat adipocytes insulin prevented D,L-isopro-
terenol from reducing the glycogen synthase activity
ratio. This blocking action means that £>,L-isoproter-
enol blocked the ability of insulin to increase the
glycogen synthase activity ratio. Our results show
that, in human polymorphonuclear leukocytes, not
only AL-isoproterenol but also L-thyroxine can de-
crease the glycogen synthase activity ratio, which is
known to be increased by simultaneous incubation
with glucose and insulin. We also examined the effect
of Z),L-isoproterenol and L-thyroxine on the glycogen
phosphorylase activity ratio suppressed by glucose.
Both reagents increased the glycogen phosphorylase
activity ratio which should have been decreased by
glucose.
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In conclusion, suppression of glycogen synthase and
enhancement of glycogen phosphorylase activities by
thyroid hormone and a ß-agonist impair the glycogen
metabolism in human polymorphonuclear leukocytes.
Although the present study shows the acute effects of
thyroid hormone and a ß-agonist, if similar alterations
of these enzyme activities are observed in other human
tissues, they may have some relations to glucose in-
tolerance among hyperthyroid patients. The study of
glycogen metabolism in polymorphonuclear leuko-
cytes appears to be a useful method for elucidating
the impaired glucose tolerance in· hyperthyroidism.
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